Events
Kevin Leyden and Corey DeStefano presented the Hepatitis C Abstract at the Global Hepatitis Summitt in Los Angeles, CA 3/17/2025. Presentations were also made at IntNSA on Harm reduction nursing and the Hep C project 3/11-3/16/2025. Keystone Conference on TRANS health in Harrisburg on 3/19/2025-3/23/2025. The Team was at AIDS Watch in Washington DC and advocated on Capitol Hill 3/31-4/2/2025. Corey and Kevin will be presenting at EASL in Amsterdam on our projects 5/5-5/10/2025. Corey will provide a debrief at this Board Meeting and update on research activities, abstracts, and publications in progress. We also have abstracts that will be submitted to ID Week, APHA 2025, National Transgender Health Summit, IVHEM and INHSU. Abstracts and Presentations were approved for the following: Global Hepatitis Summitt in Los Angeles on 3/18-3/21/2025 and the International Viral Hepatitis Elimination Meeting in South Korea 9/12-9/15/2025, EASL 5/5-5/102025, National Transgender Summit 5/30-6/1/2025. Kevin Leyden and Corey DeStefano presented the Hepatitis C Abstract at the Global Hepatitis Summitt in Los Angeles, CA 3/17/2025. Presentations were also made at IntNSA on Harm reduction nursing and the Hep C project 3/11-3/16/2025. Keystone Conference on TRANS health in Harrisburg on 3/19/2025-3/23/2025. The Team was at AIDS Watch in Washington DC and advocated on Capitol Hill 3/31-4/2/2025. Corey and Kevin will be presenting at EASL in Amsterdam on our projects 5/5-5/10/2025. Corey will provide a debrief at this Board Meeting and update on research activities, abstracts, and publications in progress. We also have abstracts that will be submitted to ID Week, APHA 2025, National Transgender Health Summit, IVHEM and INHSU. Writing for upcoming conferences and journal articles: We also have abstracts that will be submitted to ID Week, APHA 2025, National Transgender Health Summit, IVHEM and INHSU. Publication in AIDS and Behavior: Link to article. Publication in Springer Journal https://pubmed.ncbi.nlm.nih.gov/39395069/ Successful funding for ChemBio Clinical Trial on a new Syphilis Rapid device ($196,775 for a 3–4-month period and Abbott Clinical Trials on Syphilis sample collection ($200,000 in a 4–6-month period). Successful funding for 2 Hepatitis C Clinical Trials with AETA Pharmaceuticals on a new hepatitis c treatment First Person screened 4/3/2024 and with Abbott on those for High risk of Hepatitis C (Contract pending and regulatory review) Successful Renewal of the NJDOH BEH Grant for Federal and State funding for the High-Risk Heterosexual Cycle (HET). Collaboration between NJCRI and NJDOH on Press Release of TRANS Data Collection on Transgender Day of Visability in March. Town hall was done on the dissemination 4/3/2025 and we are working with the Essex County LGBTQ department to disseminate our data. Gilead Projects for DOT and TRANS Liver health have been approved by the IRB and Gilead to begin. Milestone 1-2 have been met and about $103,000 has been invoiced for payment. Milestone 3 will be the enrollment period which started March 2025 and we have enrolled for both DOT and TRANS Understanding African American/Black and Latine young and emerging adults living with HIV: A sequential explanatory mixed methods study focused on self-regulatory resources” We are delighted to let you know that the above submission, which you co-authored, has been accepted for publication in International Journal for Equity in Health. Newsletter items for Research: Gilead Awards NJCRI $412,000 in Investigator based trials for TRANS Liver health and Direct observed therapy in the homeless Hep C Population NJ REACT Team has hit and surpassed their goal of 500 eligible interviews for the PWID Cycle!! Not only did the team meet and surpass their goals for this cycle but they did it 6 weeks ahead of schedule and are in the top 5 nationwide for enrollment and HIV testing for the NHBS program NJ GURRRLS Finished the first ever TRANS NHBS Survey for the CDC/DOH on 6/1/2024 with 189 TRANS participants!! MMP Meets Benchmark 8 week early! Awarded new clinical trials for vaccines for CMV and HSV from Glaxo Smith Kline LGBTQ Service Award Recipient for NJ REACT and NJ GURRRLS NJCRI Awarded over 750,000 in NIH Grant Funding for Ganchero Project , SOS- Prompt and OGM 2023/2024 Conferences that we presented our work at : (Pics Attached) Posters are in the M Drive: Publications and Abstracts Global Hepatitis Summit Paris France 4/25-4/28/2023 American Society for Nutrition Boston, MA 7/22-7/25/2023 ID Week 10/11-10/14/2023 Boston, MA Internation Conference on Hepatitis in Substance Users INHSU Conference Geneva, Switzerland 10/16-10/20/2023 American Public Health Conference (APHA) Conference Atlanta, GA 11/12-11/15/2023 IVHEM Amsterdam, Netherlands 12/1-12/3/2023 World Hepatitis Summit, Lisbon, Portugal 4/9-4/11/2023 National Latinx Conference on HIV, Hepatitis and STIs San Jose, TX May 2-4, 2024. Synchronicity Conference National Conference on HIV/HCV/STI/Harm Reduction, LGBTQ Health, 5/31/2024-6/3/2024 Washington, DC ADLM Conference July 28 – August 4, 2024, Chicago, Illinois National Ryan White Conference on HIV Care and Treatment, Washington, DC August 20-23, 2024. Philadelphia Transgender Wellness Conference Philadelphia, PA 9/7-9/9/2024 International Conference on Health and Hepatitis in Substance Users, Athens Greece, October 8-11, 2024. ID Week, Los Angeles, CA October 16-19, 2024. American Public Health Association (APHA) October 27-30, 2024 Minneapolis, MN 2023/2024 Publications and Abstracts Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Diana Finkel, DO, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN North Jersey Community Research Initiative (NJCRI), Newark, NJ. Understanding Hepatitis C Reinfection and Factors Associated with HCV Infection in New Jersey, USA. Global Hepatitis Summit April 25-28, 2023, Paris France. Joachim D. Sackey, Mina Ghbrial, Corey Rosmarin-DeStefano, Mishal Khan, Syd Rosen, Juan Torres, Diana Finkel. Food Insecurity, Community Belongingness and Social Support among Adult Transgender Individuals in Newark, New Jersey. American Society for Nutrition, July22-25, 2023, Boston, MA Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN, Evelyn Chavez, Armanious, D, Armanious A, Olsson, T, MPH. North Jersey Community Research Initiative (NJCRI), Newark, NJ. Impact of an Innovative Community Based Contracted Pharmacy on HCV Elimination in New Jersey, ID Week, October 11-14, 2023 Boston, MA. Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Diana Finkel, DO, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN North Jersey Community Research Initiative (NJCRI), Newark, NJ. Understanding
